Last10K.com

Creative Medical Technology Holdings, Inc. (CELZ) SEC Filing 8-K Material Event for the period ending Tuesday, December 22, 2020

Creative Medical Technology Holdings, In

HISTORY TOOLS
CIK: 1482278 Ticker: CELZ

View differences made from one to another to evaluate Creative Medical Technology Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Creative Medical Technology Holdings, Inc..

Continue

Assess how Creative Medical Technology Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Creative Medical Technology Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Creative Medical Technology Holdings, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Press Release
Exhibit 99.2: Press Release
Exhibit 99.3: Press Release
Ticker: CELZ
CIK: 1187953
Form Type: 8-K Corporate News
Accession Number: 0001477932-21-000025
Submitted to the SEC: Mon Jan 04 2021 4:05:17 PM EST
Accepted by the SEC: Mon Jan 04 2021
Period: Tuesday, December 22, 2020
Industry: Biological Products No Disgnostic Substances
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/celz/0001477932-21-000025.htm